BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37763782)

  • 1. Effects of Aphrodite (an Herbal Compound) on SSRI-Induced Sexual Dysfunctions and Depression in Females with Major Depressive Disorder: Findings from a Randomized Clinical Trial.
    Shahmoradi N; Davarinejad O; Brühl AB; Brand S
    Medicina (Kaunas); 2023 Sep; 59(9):. PubMed ID: 37763782
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant Rosa Damascena has a Small Effect on SSRI-induced Sexual Dysfunction in Female Patients Suffering from MDD.
    Farnia V; Hojatitabar S; Shakeri J; Rezaei M; Yazdchi K; Bajoghli H; Holsboer-Trachsler E; Brand S
    Pharmacopsychiatry; 2015 Jul; 48(4-5):156-63. PubMed ID: 26098128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant-induced sexual dysfunction during treatment with fluoxetine, sertraline and trazodone; a randomized controlled trial.
    Khazaie H; Rezaie L; Rezaei Payam N; Najafi F
    Gen Hosp Psychiatry; 2015; 37(1):40-5. PubMed ID: 25467077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline.
    Croft H; Settle E; Houser T; Batey SR; Donahue RM; Ascher JA
    Clin Ther; 1999 Apr; 21(4):643-58. PubMed ID: 10363731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
    Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
    J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial.
    Talaei A; Hassanpour Moghadam M; Sajadi Tabassi SA; Mohajeri SA
    J Affect Disord; 2015 Mar; 174():51-6. PubMed ID: 25484177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram.
    Jacobsen PL; Nomikos GG; Zhong W; Cutler AJ; Affinito J; Clayton A
    CNS Spectr; 2020 Feb; 25(1):50-63. PubMed ID: 31010445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
    Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH
    J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of adjuvant omega-3-polyunsaturated fatty acids on depression, sleep, and emotion regulation among outpatients with major depressive disorders - Results from a double-blind, randomized and placebo-controlled clinical trial.
    Jahangard L; Sadeghi A; Ahmadpanah M; Holsboer-Trachsler E; Sadeghi Bahmani D; Haghighi M; Brand S
    J Psychiatr Res; 2018 Dec; 107():48-56. PubMed ID: 30317101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sexual function improves as depressive symptoms decrease during treatment with escitalopram: results of a naturalistic study of patients with major depressive disorder.
    Weber S; Frokjaer VG; Armand S; Nielsen JH; Knudsen GM; Joergensen MB; Stenbaek DS; Giraldi A
    J Sex Med; 2023 Feb; 20(2):161-169. PubMed ID: 36763929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial.
    Jain N; Wan F; Kothari M; Adelodun A; Ware J; Sarode R; Hedayati SS
    BMC Nephrol; 2019 Oct; 20(1):395. PubMed ID: 31664940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study.
    Safarinejad MR
    BJU Int; 2010 Sep; 106(6):840-7. PubMed ID: 20067456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: results from a double-blind, randomized, and placebo-controlled clinical trial.
    Farnia V; Shirzadifar M; Shakeri J; Rezaei M; Bajoghli H; Holsboer-Trachsler E; Brand S
    Neuropsychiatr Dis Treat; 2015; 11():625-35. PubMed ID: 25834441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study.
    Kashani L; Raisi F; Saroukhani S; Sohrabi H; Modabbernia A; Nasehi AA; Jamshidi A; Ashrafi M; Mansouri P; Ghaeli P; Akhondzadeh S
    Hum Psychopharmacol; 2013 Jan; 28(1):54-60. PubMed ID: 23280545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial.
    Lewis G; Duffy L; Ades A; Amos R; Araya R; Brabyn S; Button KS; Churchill R; Derrick C; Dowrick C; Gilbody S; Fawsitt C; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Khan N; Lanham P; Pervin J; Peters TJ; Riozzie D; Salaminios G; Thomas L; Welton NJ; Wiles N; Woodhouse R; Lewis G
    Lancet Psychiatry; 2019 Nov; 6(11):903-914. PubMed ID: 31543474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crocus Sativus L. (saffron) versus sertraline on symptoms of depression among older people with major depressive disorders-a double-blind, randomized intervention study.
    Ahmadpanah M; Ramezanshams F; Ghaleiha A; Akhondzadeh S; Sadeghi Bahmani D; Brand S
    Psychiatry Res; 2019 Dec; 282():112613. PubMed ID: 31669837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI.
    Ahrold TK; Meston CM
    J Sex Marital Ther; 2009; 35(4):311-9. PubMed ID: 19466669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual side effects of SSRI medications: potential treatment strategies for SSRI-induced female sexual dysfunction.
    Kanaly KA; Berman JR
    Curr Womens Health Rep; 2002 Dec; 2(6):409-16. PubMed ID: 12429073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
    Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
    Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.